Milwaukee, WI 的 克隆氏症 臨床試驗
8 項針對 克隆氏症 的研究正在 Milwaukee（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Wisconsin Center for Advanced Research /ID# 284250, Milwaukee
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Wisconsin Center for Advanced Research, Milwaukee
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Froedtert Hospital and the Medical College of Wisconsin-Site Number: 8400081, Milwaukee
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
招募中3 期
- Medical College of Wisconsin Cancer Center - Froedtert Hospital, Milwaukee
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
招募中4 期
- Medical College of Wisconsin, Milwaukee
Precise Infliximab Exposure and Pharmacodynamic Control
招募中2/3 期
- Medical College of Wisconsin, Children's of Wisconsin, Milwaukee
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
招募中2 期
- Mirador Therapeutics Selected Site, Milwaukee
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
招募中觀察性研究歡迎健康志工
- Brain Inflammation Collaborative, Delafield · 距離 25 英里
其他城市的 克隆氏症 試驗
- New York City, NY35 項研究
- Boston, MA19 項研究
- Miami, FL19 項研究
- Cleveland, OH19 項研究
- St. Louis, MO19 項研究
- Tyler, TX17 項研究
- Orlando, FL17 項研究
- Houston, TX17 項研究
- Atlanta, GA17 項研究
- San Antonio, TX15 項研究
- Los Angeles, CA15 項研究
- San Diego, CA15 項研究
Milwaukee 的其他研究
- 乳癌23 項研究
- 癌症（所有類型）22 項研究
- 非小細胞肺癌22 項研究
- 多發性骨髓瘤21 項研究
- 肺癌21 項研究
- 前列腺癌20 項研究
- 濾泡性淋巴瘤19 項研究
- 非霍奇金淋巴瘤18 項研究
- 胰臟癌18 項研究
- 急性髓系白血病17 項研究
- 卵巢癌17 項研究
- 瀰漫性大B細胞淋巴瘤16 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。